The association of serum β2M with hard clinical outcomes and its predictive ability was also examined in a prospective cohort study on behalf of the CKD Biomarker Consortium and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators (196). The gene discussed is B2M; the disease is chronic kidney disease.